At the forefront of pharmaceutical innovation, Virupaksha stands out for its unwavering commitment to delivering excellence in manufacturing high-purity Fluconazole, a critical medication in the fight against cryptococcal meningitis. With certifications that underscore their dedication to quality and safety—such as WHO-GMP compliance and ISO 9001 for superior quality management systems alongside ISO 14001 for environmental stewardship—Virupaksha ensures that every batch produced meets stringent global standards.
Their state-of-the-art facilities are meticulously designed to uphold these standards, utilizing advanced technologies that enable precise control over production processes while minimizing environmental impact. This relentless pursuit of excellence not only reinforces their reputation as a trusted partner in healthcare but also significantly contributes to improving patient outcomes across diverse populations afflicted by this serious fungal infection.
Other Latest News
- The Health Shift July 19, 2025 8:28 am MedEdge MEA Self-confidence and self-reliance might seem like two sides of the same coin, but they each tell a unique story of strength. Self-confidence is that inner spark, pushing you to believe in your own potential. Self-reliance? It’s about standing tall on your …
- Sigachi disaster: The blast must jolt pharma regulators out of their slumber July 19, 2025 2:05 am Mint The blast—which claimed the lives of 44 workers and critically injured 33 more, with eight officially listed as “missing"—has once again put the spotlight on shortcomings in occupational safety and GMP (good manufacturing practice) compliance in India …
- 9 Things to Know About Big Pharma, in Charts July 19, 2025 12:41 am The Epoch Times Nine snapshots of the fast-growing global pharmaceutical industry. The Epoch Times | July 18, 2025Updated:July 18, 2025 Prescription drugs provide relief from pain, fight infection, stabilize moods, reduce inflammation, combat dread diseases, and extend …
- HEM Pharma Opens Advanced Bio-Manufacturing Factory inSejong July 18, 2025 10:02 pm Business Korea HEM Pharma, a microbiome-based healthcare company, announced on July 18 that it has held a completion ceremony for its newly established factory in the Smart Green Industrial Complex in Sejong Special Self-governing City and has begun full-scale operations …
- MEI Pharma bets $100m on Litecoin as Charlie Lee joins board July 18, 2025 9:13 pm crypto.news The Nasdaq-listed biotech firm is making an unprecedented pivot into crypto, committing $100 million to a Litecoin treasury strategy, with the coin’s creator, Charlie Lee, now at the helm. In a press release dated July 18, the Litecoin Foundation announced …
- Pharma Pulse 7/18/25: How Parexel Supports Cross Functional Trials for Emerging GLP-1 Therapies; Eisai Explores Novel Dual Mechanism Therapy for Advanced Endometrial Carcinoma July 18, 2025 6:47 pm Pharmaceutical Commerce How Parexel Supports Cross Functional Trials for Emerging GLP-1 Therapies In an interview with Applied Clinical Trials, Shipra Patel, global therapeutic area section head for endocrinology and global head of pediatrics at Parexel, explained how the company …
- LTC Soars 3% as MEI Pharma Announces $100M Litecoin Treasury Strategy July 18, 2025 5:57 pm Crypto Economy TL;DR MEI Pharma has unveiled a $100 million Litecoin treasury plan in collaboration with Titan Partners Group and crypto giant GSR. Litecoin creator Charlie Lee will join MEI’s Board, reinforcing the project’s credibility and long-term vision. The …
- Nasdaq-listed MEI Pharma launches $100M Litecoin treasury plan, stock rockets 50% July 18, 2025 4:08 pm Crypto Briefing Key Takeaways MEI Pharma is launching a $100 million Litecoin treasury plan with backing from the Litecoin Foundation and major crypto partners. Litecoin creator Charlie Lee will join MEI Pharma's Board, aiming to expand global Litecoin adoption …
- GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee July 18, 2025 2:04 pm Finbold Press Releases are sponsored content and not a part of Finbold's editorial content. For a full disclaimer, please click here. Crypto assets/products can be highly risky. Never invest unless you’re prepared to lose all the money you invest. NEW YORK …
- Pharma Contract Research Organization (CRO) Services Market to Cross USD 36.66 Billion in 2025, Expanding at a CAGR of 10.04% July 18, 2025 2:00 pm EIN Presswire Ottawa, July 18, 2025 (GLOBE NEWSWIRE) — The global pharma contract research organization (CRO) services market size was valued at USD 33.31 billion in 2024 and is predicted to hit around USD 87.03 billion by 2034, a study published by Towards Healthcare …
- Scaling up green chemistry principles for pharma manufacturing July 18, 2025 1:08 pm European Pharmaceutical Manufacturer New environmental regulations and increasing consumer demand for corporate sustainability drive European pharmaceutical companies to commit to green chemistry processes. Ellie Gabel, associate editor for Revolutionized discusses. Scaling up ecologically …
- Royalty Pharma Declares Third Quarter 2025 Dividend July 18, 2025 12:15 pm EIN Presswire NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on September 10, …
- Lupin arm Dabhasa facility gets GMP certification from TGA Australia July 18, 2025 11:51 am Medical Dialogues Mumbai: Global pharma major Lupin Limited has announced that the API manufacturing facility of its wholly owned subsidiary, Lupin Manufacturing Solutions (LMS), in Dabhasa, Gujarat, has received the Good Manufacturing Practice (GMP) certification from the …
- Astellas and KISED link to support Korean pharma startups July 18, 2025 11:50 am Pharmaceutical Technology Astellas Pharma has entered a memorandum of understanding (MoU) with the Korea Institute of Startup and Entrepreneurship Development (KISED) to support Korean pharmaceutical startups’ global growth. Astellas and KISED will operate the Partnership with …
- HDFC AMC, Tata Communications, Torrent Pharma Share Price Jumps; HDFC AMC Trades at All-Time Highs July 18, 2025 9:05 am Top News HDFC AMC, Tata Communications, and Torrent Pharmaceuticals have given bullish breakout on technical charts. HDFC AMC is currently trading at all-time highs and we can see further momentum in this counter. Tata Communications was trading 2 percent higher in …
- Tariff delay sparks relief rally in Indian pharma stocks: Sudip Bandyopadhyay July 18, 2025 8:47 am The Economic Times "The uncertainty is not around demand or the price hike but the uncertainties are company specific. JSW Steel, we will definitely want to hear what is their strategy about Bhushan Steel, that is a huge problem which has been created in the recent past …
- Nifty opens lower despite global rally as FII selling continues July 18, 2025 8:20 am The Hindu Business Line Markets opened on a cautious note on Friday, with the Sensex opening at 82,193.62, slightly lower than its previous close of 82,259.24, and slipping further to 81,969.08 at 9:50 am, down 290.16 points or 0.35 per cent. The Nifty 50 also opened flat at 25, …
- Venus Remedies secures WHO GDP endorsement for best-in-class pharma logistics July 18, 2025 8:15 am Pharmabiz.com Venus Remedies, a leading research-driven pharmaceutical company, has once again received the World Health Organization (WHO) Good Distribution Practices (GDP) Certification for its supply chain unit-II in Baddi, Himachal Pradesh, from Société Générale de …
- MSC Air Cargo approves Swiss Airtainer RKN for global operations July 18, 2025 7:31 am STAT Trade Times Swiss Airtainer SA has announced that MSC Air Cargo has officially approved its flagship RKN container for use across the airline’s global air freight network. This milestone adds another major carrier to Swiss Airtainer’s growing list of partners and …
- Astellas partners with the KISED for the operation of the 'Partnership with Global Companies Programme' July 18, 2025 4:41 am Pharmabiz.com Astellas Pharma Inc., a global life sciences company, announced that it has agreed on a memorandum of understanding (MoU) with the Korea Institute of Startup and Entrepreneurship Development (KISED), an umbrella organization of the Ministry of SMEs and …
- Latest News | Torrent Pharma Seeks CCI Nod to Acquire Majority Stake in JB Chemicals for Rs 19,500 Cr July 18, 2025 4:25 am Latestly New Delhi, Jul 18 (PTI) Ahmedabad-based Torrent Pharmaceuticals has sought fair trade regulator CCI's clearance to acquire a majority stake in in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. After the completion of the deal, Torrent …
- Zuellig Pharma Strengthens Healthcare Access in Thailand July 18, 2025 4:13 am Bangkok Post Strategic investment and partnerships drive innovation, equity, and reach across Thailand’s evolving healthcare landscape. PUBLISHED : 18 Jul 2025 at 08:00 As Thailand navigates a shifting healthcare landscape marked by ageing populations and rising rates …
- Torrent Pharma seeks CCI nod to acquire majority stake in JB Chemicals for Rs 19,500 cr July 18, 2025 4:07 am The Economic Times New Delhi, Ahmedabad-based Torrent Pharmaceuticals has sought fair trade regulator CCI's clearance to acquire a majority stake in in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. After the completion of the deal, Torrent Pharmaceuticals …
- Experts analyse OBBBA’s impact on Indian pharma industry July 18, 2025 3:37 am Pharmabiz.com The One Big Beautiful Bill Act (OBBBA), signed into law by US President Trump on July 4, 2025, includes provisions that introduce a 1% excise tax on certain outbound remittances by non-US citizens, reduced from an initial proposal of 5%. This has generated …
- US FDA 200+CRLs to help pharma industry engage in a more transparent manner: Experts July 18, 2025 3:37 am Pharmabiz.com US FDA 200+Complete Response Letters (CRLs) of drugs and biological products between 2020 and 2024 released on July 10, 2025 will help pharma industry to engage in a more transparent manner, according to experts. Experts further explain that this will …
